Evidence map›Paper›PMID 27826132›Full record

ArticleJMIR medical informatics2016

Increasing Complexity in Rule-Based Clinical Decision Support: The Symptom Assessment and Management Intervention.

David F Lobach, Ellis B Johns, Barbara Halpenny, Toni-Ann Saunders, Jane Brzozowski, Guilherme Del Fiol, Donna L Berry, Ilana M Braun, Kathleen Finn, Joanne Wolfe and 2 more

Abstract read
In one paragraph

Article in JMIR medical informatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  8. Article
  9. Article
  10. Medical knowledge infused convolutional neural networks for cohort selection in clinical trials.Journal of the American Medical Informatics Association : JAMIA · 2019
    Article
  11. Clinical trial cohort selection based on multi-level rule-based natural language processing system.Journal of the American Medical Informatics Association : JAMIA · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David F LobachSchool of Medicine, Department of Community & Family Medicine, Duke University, Durham, NC, United States.ORCID http://orcid.org/0000-0001-6126-6441
Ellis B JohnsFamily Medicine of Albemarle, Charlottesville, VA, United States.ORCID http://orcid.org/0000-0002-3471-295X
Barbara HalpennyDana-Farber Cancer Institute, The Phyllis F. Cantor Center, Boston, MA, United States.ORCID http://orcid.org/0000-0001-6273-8674
Toni-Ann SaundersDana-Farber Cancer Institute, The Phyllis F. Cantor Center, Boston, MA, United States.ORCID http://orcid.org/0000-0002-3434-9636
Jane BrzozowskiIndependent Clinical Informatics Consultant, Boston, MA, United States.ORCID http://orcid.org/0000-0002-8833-5782
Guilherme Del FiolDepartment of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States.ORCID http://orcid.org/0000-0001-9954-6799
Donna L BerryDana-Farber Cancer Institute, The Phyllis F. Cantor Center, Boston, MA, United States.ORCID http://orcid.org/0000-0001-7935-2807
Ilana M BraunDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID http://orcid.org/0000-0003-3532-7057
Kathleen FinnCity of Hope, Clinical Trials Office, Duarte, CA, United States.ORCID http://orcid.org/0000-0003-4066-6416
Joanne WolfeDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID http://orcid.org/0000-0002-4406-7413
Janet L AbrahmDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, United States.ORCID http://orcid.org/0000-0002-7737-1323
Mary E CooleyDana-Farber Cancer Institute, The Phyllis F. Cantor Center, Boston, MA, United States.ORCID http://orcid.org/0000-0001-5353-9542

Funding

A lung cancer symptom assessment and management interventionR01CA125256 · NCI · DANA-FARBER CANCER INST · PI COOLEY, MARY E · 2008 to 2011
$1.9M
NCI NIH HHS R01 CA125256
6 · The paper itself

Abstract

backgroundManagement of uncontrolled symptoms is an important component of quality cancer care. Clinical guidelines are available for optimal symptom management, but are not often integrated into the front lines of care. The use of clinical decision support (CDS) at the point-of-care is an innovative way to incorporate guideline-based symptom management into routine cancer care.

objectiveThe objective of this study was to develop and evaluate a rule-based CDS system to enable management of multiple symptoms in lung cancer patients at the point-of-care.

methodsThis study was conducted in three phases involving a formative evaluation, a system evaluation, and a contextual evaluation of clinical use. In Phase 1, we conducted iterative usability testing of user interface prototypes with patients and health care providers (HCPs) in two thoracic oncology clinics. In Phase 2, we programmed complex algorithms derived from clinical practice guidelines into a rules engine that used Web services to communicate with the end-user application. Unit testing of algorithms was conducted using a stack-traversal tree-spanning methodology to identify all possible permutations of pathways through each algorithm, to validate accuracy. In Phase 3, we evaluated clinical use of the system among patients and HCPs in the two clinics via observations, structured interviews, and questionnaires.

resultsIn Phase 1, 13 patients and 5 HCPs engaged in two rounds of formative testing, and suggested improvements leading to revisions until overall usability scores met a priori benchmarks. In Phase 2, symptom management algorithms contained between 29 and 1425 decision nodes, resulting in 19 to 3194 unique pathways per algorithm. Unit testing required 240 person-hours, and integration testing required 40 person-hours. In Phase 3, both patients and HCPs found the system usable and acceptable, and offered suggestions for improvements.

conclusionsA rule-based CDS system for complex symptom management was systematically developed and tested. The complexity of the algorithms required extensive development and innovative testing. The Web service-based approach allowed remote access to CDS knowledge, and could enable scaling and sharing of this knowledge to accelerate availability, and reduce duplication of effort. Patients and HCPs found the system to be usable and useful.

Indexed as

clinical algorithmslung cancerpatient-reported outcomesrule-based clinical decision supportsoftware as a servicesymptom managementWeb services

Identifiers

PMID27826132
PMCPMC5120240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.